日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia

XANAP:一项在亚洲开展的真实世界、前瞻性观察性研究,旨在评估利伐沙班治疗房颤患者预防卒中的效果。

Kim, Young-Hoon; Shim, Jaemin; Tsai, Chia-Ti; Wang, Chun-Chieh; Vilela, Gilbert; Muengtaweepongsa, Sombat; Kurniawan, Mohammad; Maskon, Oteh; Li Fern, Hsu; Nguyen, Thang Huy; Thanachartwet, Thititat; Sim, Kenneth; Camm, A John